Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats.

scientific article published on 25 January 2012

Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PNPBP.2012.01.009
P698PubMed publication ID22300747

P2093author name stringPrashant Deshmukh
Pravinkumar Bhutada
Yogita Mundhada
Anand Rahigude
Kishor Jain
Sandeep Latad
Vishwas Humane
P433issue1
P921main subject2-imidazolineQ419555
P304page(s)96-105
P577publication date2012-01-25
P1433published inProgress in Neuro-Psychopharmacology & Biological PsychiatryQ15616665
P1476titleAgmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats.
P478volume37

Reverse relations

cites work (P2860)
Q39379707Agmatine protects rat liver from nicotine-induced hepatic damage via antioxidative, antiapoptotic, and antifibrotic pathways
Q37098939Diabetes Impairs Wnt3 Protein-induced Neurogenesis in Olfactory Bulbs via Glutamate Transporter 1 Inhibition
Q95643364Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
Q87161227Protective effect of diosmin against diabetic neuropathy in experimental rats
Q48095799The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.

Search more.